Testing effectiveness (Phase 2)Not Yet RecruitingNCT07841496
What this trial is testing
ALT001 in Patients With Ischemic Stroke in the Sequelae Stage
Who this might be right for
Ischemic Stroke in the Sequelae Stage
Darwin Origin (Hubei) Biopharmaceutical Co., Ltd. 200